WO2008028011A2 - Compositions and methods for preserving permeation layers for use on active electronic matrix devices - Google Patents

Compositions and methods for preserving permeation layers for use on active electronic matrix devices Download PDF

Info

Publication number
WO2008028011A2
WO2008028011A2 PCT/US2007/077188 US2007077188W WO2008028011A2 WO 2008028011 A2 WO2008028011 A2 WO 2008028011A2 US 2007077188 W US2007077188 W US 2007077188W WO 2008028011 A2 WO2008028011 A2 WO 2008028011A2
Authority
WO
WIPO (PCT)
Prior art keywords
permeation layer
sugar
permeation
solution
raffinose
Prior art date
Application number
PCT/US2007/077188
Other languages
French (fr)
Other versions
WO2008028011A3 (en
Inventor
James P. Ii Light
Kenny V. Nguyen
Original Assignee
Nanogen Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nanogen Inc. filed Critical Nanogen Inc.
Publication of WO2008028011A2 publication Critical patent/WO2008028011A2/en
Publication of WO2008028011A3 publication Critical patent/WO2008028011A3/en

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N27/00Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
    • G01N27/26Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
    • G01N27/28Electrolytic cell components
    • G01N27/30Electrodes, e.g. test electrodes; Half-cells
    • G01N27/327Biochemical electrodes, e.g. electrical or mechanical details for in vitro measurements
    • G01N27/3271Amperometric enzyme electrodes for analytes in body fluids, e.g. glucose in blood

Definitions

  • the present invention provides improved synthetic polymer hydrogel permeation layers for use on active electronic matrix devices for biological assays.
  • the hydrogel permeation layers incorporate a dried coating of raff ⁇ nose or combination of raffinose and stachyose to protect the permeation layer from degradation, thereby increasing shelf-life and expanding permissible shipping and storage temperatures.
  • the present invention provides increased cartridge-to-cartridge and lot-to-lot consistency during fabrication.
  • the present invention also provides a preservative method for synthetic polymer hydrogel permeation layers having copolymerized attachment sites for biomolecules of interest, such as nucleic acid probes.
  • nucleic acid probes By placing a plurality of nucleic acid probes on a surface, and exposing the surface to a sample containing target nucleic acids, many hybridization reactions may be carried out on a sample at the same time, simultaneously generating hybridization data for several target nucleic acids (the reverse dot-blot technique). Similarly, by immobilizing nucleic acids from several samples onto the surface, several samples may be probed with the same oligonucleotide probe at the same time (the dot-blot technique). Originally, dot- blot and reverse dot-blot hybridizations were carried out using nucleic acid probes crudely blotted onto a nucleic acid-binding membrane or filter.
  • nucleic acid probes In the past few decades, several tools have been designed to place nucleic acid probes at defined locations in high densities on various types of surfaces (glass, polymers, silicon nitride, etc.) by methods such as physical deposition (e.g., ink-jet, microspray, pin deposition, microchannel deposition) or by in-situ polymerization techniques (e.g., photo-deprotection methods.)
  • Such "microchip" based DNA arrays have been of great interest in recent years due to their enormous ability to facilitate rapid analysis of genetic information. Although very advanced techniques are utilized to generate these types of arrays, they still employ parallel hybridization of DNA to the immobilized capture probes in a passive mode. In other words, the nucleic acids present in the entire sample volume interact with the entire array surface at the same time, to the same extent.
  • active electronic matrix arrays use an electric field to facilitate the rapid transport and hybridization of DNA on microchips.
  • active matrix array devices contain an array of electronically addressable microelectrodes on a substrate, which provide electric field control over a variety of biomolecular reactions including DNA transport, hybridization and denaturation.
  • the electrodes By using the electrodes to apply an electric field to a solution containing charged molecules, such as nucleic acids, the charge molecules can be rapidly transported to and concentrated at the electrodes which are biased opposite the charge of the molecules.
  • the devices comprise an array of individually controllable microelectrodes on a substrate, and optionally comprise additional counter electrodes for opposite biasing.
  • the microelectrodes are overlaid by a thin permeation layer, defining the microlocations of the device above the microelectrodes.
  • the permeation layer separates the biomolecules from the electrode surface where hydrolysis and other potentially detrimental electrochemical reactions can occur. Although the permeation layer retards or prohibits the movement of the biomolecules towards the microelectrode, the permeation layer is sufficiently permeable to small molecules to permit ion exchange between the electrode surface and the buffer medium, allowing an electric current to flow.
  • the active electronic matrix chips usually use electric current and voltage conditions wherein electric current densities are at least 0.04 nA/ ⁇ m 2 (about 200 nA for an 80 ⁇ m diameter microlocation) and/or potentials sufficient to hydrolyze water.
  • the electric current density is defined as the electric current divided by the area of the electrode used to support it.
  • the effectiveness of the translocation of charged biomolecules such as nucleotide oligomers within an electronically-driven system such as an active electronic matrix chip depends on the generation of the proper gradient of positively and negatively charged electrochemical species by the anode and cathode, respectively.
  • effective nucleic acid i.e. either DNA or RNA
  • SCE saturated calomel electrode
  • the permeation layer of active electronic matrix devices is an important element in the overall function of the device. It must be sufficiently permeable to small aqueous ions, yet efficiently sequester biomolecules from the electrode surface. In addition, it must be able to withstand significant chemical and mechanical forces while maintaining its integrity and shape.
  • SA glyoxal crosslinked streptavidin
  • Agarose is a naturally sourced carbohydrate polymer hydrogel, containing long polymer strands which are crosslinked by non-covalent bonding.
  • Such hydrogels are referred to as “physical hydrogels,” as they derive their structure from non-covalent interactions, as compared to “chemical hydrogels,” which derive their structure from covalent bonds (or cross-links) between the polymer strands.
  • Agarose permeation layers provide good relative fluorescent intensity measurements in nucleic acid assays such as hybridization assays for single nucleotide polymorphisms (SNPs) and short tandem repeat sequences (STRs) in amplicon and capture-sandwich formats, and also in primer-extension type nucleic acid assays which have been used for gene-expression analysis.
  • SNPs single nucleotide polymorphisms
  • STRs short tandem repeat sequences
  • Polyacrylamide and other synthetic polymer gels offer an alternative to agarose hydrogel permeation layers. These materials are wholly synthetic, and thus offer strict quality control of the components. In addition, they may be easily molded onto the microelectrode array surface with a high degree of uniformity across the entire device. Permeation layers which are between 1 and 2 ⁇ m thick in the dry state can be easily produced in this manner, and are amendable to high-throughput manufacture. After molding, streptavidin is covalently linked to the surface of the hydrogel to provide attachment sites for biotinylated oligonucleotide probes or amplicons.
  • the current invention provides a dried coating of raff ⁇ nose or a combination of raffinose and stachyose that serves to preserve and protect the permeation layer from degradation, increase the shelf-life, and expand the permissible storage and shipping temperatures for cartridges containing permeation layers.
  • a permeation layer having copolymerized attachment sites is preserved and protected through addition of a dried raffinose coating.
  • a combination of raffinose and stachyose is dried onto the permeation layer.
  • the raff ⁇ nose or combination of raffinose and stachyose coatings are formed by dissolving the sugar up to 10% (w/v) in 0.05% Proclin in deionized water. The resulting sugar solutions are then dispensed onto the permeation layers so as to saturate the permeation layer and subsequently allowed to dry at ambient temperatures. The dried coating may be washed away with commonly used buffers or water when the permeation layer is ready for use.
  • the present invention discloses a method of coating a permeation layer overlying an electrode on a substrate including the steps of preparing a permeation layer, which may include, for example, a hydrogel or a sol-gel, preparing a sugar-based preservative solution, covering the permeation layer with the preservative solution and allowing the preservative solution to dry on the permeation layer.
  • a permeation layer which may include, for example, a hydrogel or a sol-gel
  • preparing a sugar-based preservative solution covering the permeation layer with the preservative solution and allowing the preservative solution to dry on the permeation layer.
  • the sugar-based preservative solution contains up to about 10% raffinose
  • the preservative solution contains a mixture of raffinose and stachyose in an amount up to about 10% by weight.
  • the sugar- based preservative solution contains about 5% raffinose and about 5% stachyose by weight; other embodiments use a sugar-based preservative solution having about 1% raffinose and about 9% stachyose. In still other embodiments, the sugar-based preservative solution has a concentration of about 0% raffinose and about 10% stachyose by weight.
  • Fig. 1 is a chart showing a plot of the weight of various solutions as a function of the drying time.
  • Fig. 2 is a chart showing a plot of the average evaporation rate of various solutions.
  • the ion-permeable permeation layer which overlies the electrodes of the microlocations, or active sites, of these devices.
  • the permeation layer provides attachment moieties for the attachment and immobilization of nucleic acids (or other specific binding entities, such as antibodies, or synthetic binding moieties such as pyranosyl-RNA). More importantly, the permeation layer separates the attached or tethered oligonucleotides and hybridized target DNA sequences from the highly reactive electrochemical environment generated immediately at the electrode surface.
  • the permeation layer allows oligonucleotides and DNA fragments to be electronically concentrated above, rather than on, the electrode surface and hybridized to anchored complementary oligonucleotides while being protected from the reactive electrode surface and its immediate environment.
  • the permeation layer also allows the gradual diffusion of the electrochemical reaction products (H + , OH ' , gasses, etc.) into the solution around the microlocation, allowing these products to balance the charge through the permeation layer by ion exchange and to react with buffer species.
  • the design of the microelectrode and permeation layer, forming a microlocation structure allows high current densities to be achieved in a very confined area, while minimizing the adverse effects produced by the electrode itself.
  • the ability to produce a precisely controlled high current level, or density, at individual microlocations even allows the selective "de-hybridization" of DNA fragments, achieving hybridization selectivity at the level of single base mismatches.
  • the devices can further improve the specificity of assays and reactions by providing another parameter to encourage mismatch de-hybridization (along with the more traditional parameters of temperature and chemical environment), which is known as “electronic stringency", or “electronic stringency control (ESC).”
  • ESC overcomes an inherent limitation of conventional array technologies, which must rely on stringency conditions which are consistent for all sites over the entire array.
  • the active devices of this invention can electronically produce different stringency conditions at each microlocation.
  • hybridization adds another controllable factor affecting hybridization, along with the more traditional factors such as temperature, salt concentration and the presence of chaotropic agents.
  • all hybridizations can be carried out optimally in the same bulk solution, and multiple hybridization reactions can be carried out with minimal outside physical manipulations. Additionally, it may be unnecessary to change temperature in some cases, and the need for multiple washing procedures is greatly reduced.
  • the permeation layer of active electronic matrix devices is more than simply a mechanical support to hold attachment sites for specific binding entities. It is also an important factor in the overall performance and efficiency of the devices in their active electronic modes. Unlike coatings or gel supports which have been described for passive array devices, e.g., the gel-block arrays described in U.S. Pat. No. 5,770,721, which simply use hydrogel matrices as an attachment scaffold, permeation layers used on the active electronic matrix devices described herein must also allow the efficient active electronic transport of biomolecules to the microlocations of the device, and be conducive to electronic hybridization and/or stringency procedures.
  • agarose hydrogels containing glyoxal-crosslinked streptavidin have proven to be effective permeation layer materials on active electronic matrix chip devices. In general, these permeation layer formulations have provided good mean fluorescence indices with minimal background. SNP assays run on the SA-agarose chips have demonstrated nearly 100% accuracy in several tests run with actual genomic samples, together with a high discrimination ratio for discerning between alleles in both homozygous and heterozygous samples. In addition, very good results have been obtained using SA-agarose active electronic matrix chips in STR and gene expression analysis assays.
  • SA-agarose is a physical hydrogel, which derives its semi-solid structure from non-covalent interactions between long polysaccharide chains. As these interactions are temperature-dependent, changes in temperature change the viscosity of the agarose solution: at higher temperatures, the solution is more liquid, while it forms a solidified gel at room temperature. Thus, in order to coat the agarose permeation layer onto the active electronic matrix chip electrode array, the agarose solution must be kept at a relatively high and constant temperature during the manufacturing process.
  • the current manufacturing method is to spin-coat the agarose solution onto the active electronic matrix chip surface.
  • the agarose permeation layer production methods add significantly to the resources expended in producing the device.
  • Synthetic polymer hydrogels offer a more easily controlled quality and production characteristics.
  • Synthetic polymer hydrogels are produced from individual monomeric components, which are usually synthesized themselves from basic organic chemical components. The monomers can be purified to very high quality, with identical physical and chemical characteristics between production batches. The monomeric components can be mixed in various formulas with cross-linker moieties and polymerized by a triggered initiator (e.g., by exposure of a photoinitiator to UV).
  • a triggered initiator e.g., by exposure of a photoinitiator to UV.
  • synthetic polymer hydrogels offer many advantages for mass production. They be easily molded onto the microelectrode array surface in situ with a high degree of uniformity across the entire device.
  • Microreaction molds and methods of using them to form thin, uniform, synthetic polymer hydrogel layers on the surface of active electronic matrix chips have been described in WO 01/43938, Havens et al., incorporated herein by reference in its entirety.
  • the microreaction molds disclosed comprise a mold cavity, with at least one side transparent to an electromagnetic radiation wavelength. In these systems, a small volume of the polymerization mixture (monomers, cross-linkers, and photoactivator) is placed into the mold cavity.
  • the microelectrode array substrate is then pressed against the mold, forming an enclosed volume of the polymerization mixture on the substrate.
  • the polymerization reaction is initiated by irradiating the enclosed volume with an appropriate wavelength of light for the photoinitiator (e.g., UV), and the polymerization reaction is allowed to proceed to completion.
  • an appropriate wavelength of light for the photoinitiator e.g., UV
  • the mold is removed, a thin, uniform, synthetic polymer hydrogel permeation layer has been formed on the microelectrode array.
  • Permeation layers which are between 1 and 2 ⁇ m thick, with sub-micron variations in thickness, can be easily produced in this manner, and are amendable to high- throughput manufacture.
  • Multi-layer permeation layers (either overlaid or graft- polymerized onto the prior layers) be made in this manner as well, by using a series of molds with differing depths and/or widths.
  • the molds can be designed to form individual permeation layers over each individual microelectrode, creating individually formed microlocations. In this manner, it is even possible to vary the permeation layer composition from microlocation to microlocation over the array of the active electronic matrix chip.
  • cartridges containing permeation layers for use with the NanoChipTM400 did not meet ideal shipping and storage requirements.
  • cartridges containing uncoated hydrogel permeation layers for use with Nanogen microarrays dehydrated and collapsed over time, thereby causing performance degradation.
  • addition of the sugar raffinose, alone or in combination with stachyose, to form a coating to the permeation layer resisted dessication and dramatically increased shelf-life and viability.
  • the present invention is not limited to a particular type of permeation layer. Indeed, permeation layers comprising hydrogels and sol-gels as exemplified in U.S. Patent Nos. 6,303,082 and 6,960,298 may be used in conjunction with the preservatives and methods for preserving disclosed herein.
  • a hydrogel solution was prepared and a batch of DIa ACV400 Fcos was molded.
  • the Fcos with permeation layer was washed in 0.05% Proclin water for 1 hour with out stirring, then rinsed and dried with N 2 .
  • the preservative solutions shown in Table 1 were made and 20 ⁇ l of solution was pipetted into each Fcos flow-cell.
  • the permeation layer was allowed to swell in the solutions for 20 minutes.
  • the solutions were then pipetted out of the flow-cell and dried with N 2 .
  • the Fcos was stored in nitrogen-purged desiccators for about 72 hours.
  • the Fcos permeation layers were assembled into cartridges. Finished cartridges were placed in 40 0 C incubators for accelerated stability tests.
  • the cartridge lot number was A10254. There were 29 normal DIa (APO-10, 20mg) cartridges and 41 cartridges treated with preservative solutions described in Table 1. The results are summarized in table 2 below. Table 2.
  • preservative sugar solutions were applied to APO-IO permeation layers on ACV400 Feos prior to cartridge assembly stage to investigate prolonged permeation layer shelf-life.
  • a solution of 0.005% Proclin water was prepared by adding Ig of Proclin 300 into 2L of deionized water. The mixture was stirred for 10 minutes and filtered with a 0.2 ⁇ m bottle-top filter.
  • a DIa hydrogel solution having the following mixing volume was made: 165 ⁇ l of monomer-detergent solution plus 110 ⁇ l modified Streptavidin and 30.6 ⁇ l 2% Darocur in DMSO.
  • preservative sugar solutions were introduced to APO-10 permeation layer on ACV400 Fcos prior to cartridge assembly step to prolong the permeation layer shelf-life.
  • This experiment investigated 7 different preservative solutions, which were introduced to permeation layers that had dried for 24 hours dry as well as to permeation layers that had been immediately dried. The treated perm layers were held at 23 °C and 37°C for drying.
  • the finished cartridges were labeled as indicated in the table above.
  • the first letter refers to the condition of the permeation layer when the sugar solution was added.
  • the two digit number in the middle refers to the sugar solution number.
  • the last two digit number refers to the drying temperatures after the permeation layer was coated with the sugar solution.
  • the permeation layers were re-hydrated in water for one hour and dried with nitrogen. After drying, sugar solutions were applied to the permeation layers and allowed to incubate at 23°C or 37°C for 48 hours. The rehydration step was added to determine whether the cracking observed in some sugar- coated permeation layers was the result of polymer shrinkage during dehydration.
  • a hydrogel solution was prepared. Two liters of 0.005% Proclin water were preparedand used to make preservative sugar solutions and wash the permeation layers. A 2% initiator solution was prepared by adding 11.5mg of Darocur 4265 into 575 ⁇ l of DMSO. The final hydrogel solution was formulated with the following mixing volume: 165 ⁇ l of monomer detergent, 110 ⁇ l modified streptavidin and 30.6 ⁇ l initiator solution. The solution was filtered with 0.2 ⁇ m Millex LG syringe filter.
  • the molded Fcos were rinsed with 0.005% Proclin water for five seconds each using a squirt bottle.
  • the Fcos were soaked in large Petri-dish with Proclin water for one hour and rinsed again with Proclin water.
  • the Fcos were then dried with N 2 and inspected before treatment with preservative sugar solutions.
  • PVP-treated permeation layers appear to crack when stored at room temperature or higher. Raffinose treated cartridges were more stable. All of the cartridges stored at 55 0 C for 13 days were cracked.
  • the evaporation rate of the sugar solutions was determined.
  • Six empty ACV400 Fcos (with no perm layer) were used. The weight of the Fcos was recorded before and after 15 ⁇ l of solution was dispended and evenly spread out onto the Fcos' flow-cell. Each of the Fcos were stored in a large Petri-dish with the lid closed. The Petri-dish was placed on lab bench at normal room condition (humidity was about 40 +/-10). The weights of the Fcos were measured over time to determine the evaporation rate of the solution.
  • the solutions used for this study were water, 5% ethanol, 10% Raffinose, and 10% PVP.
  • the weight of the solutions was calculated and plotted it as a function of drying time.
  • the slope of the linear fit line on graph 2 provides the average evaporation rate of the solutions.
  • the calculated dry time is 4.7 hours.
  • the 5% ethanol curve has a slightly steeper slope, indicating that the ethanol solution vaporizes faster than water and sugar solutions.
  • the end values of all the sugar solution curves at the 6 hour point were slightly higher than the water and ethanol, indicating that about 10% of the materials were left over after the water completely evaporated. Table 11.
  • Solutions of 10% raffinose and 10% stachyose were prepared.
  • the 10% stachyose solution was made by dissolving 300mg of stachyose hydrate powder onto 2.7ml of 0.05% Proclin 300 solution.
  • Test solutions were prepared by mixing the 10% Raffmose and 10% Stachyose solutions together at different volume ratios. A total of six mixtures were made as shown in the table below. Table 13.
  • test solutions were pipetted onto cover glasses, 15 ⁇ l of solution per glass, and allowed to incubate at room temperature in large Petri-dishes to evaporate.
  • cover glasses were used for each solution. Ten out of the sixty test samples were added with a very small amount of raffmose powder to catalyze crystallization of the solution.
  • FCOS All of the FCOS were inspected under a microscope and appeared to be normal after 11 days of storage at ambient conditions. The room temperature and relative humidity were recorded as shown below. Table 14.

Abstract

An improved synthetic, polymer hyrodgel permeation layer for use with an active electronic matrix device for biological assays. The permeation layer includes a dried coating of raffinose or a combination of raffinose and stachyose to protect the permeation layer from degradation during shipping and storage.

Description

S P E C I F I C A T I O N
COMPOSITIONS AND METHODS FOR PRESERVING PERMEATION LAYERS FOR USE ON ACTIVE ELECTRONIC MATRIX DEVICES
Related Applications
[0001] This patent application claims the priority benefit of U.S. Application Serial No. 11/846,187, filed August 28, 2007, which claims priority to U.S. Provisional Application Serial No. 60/841,781, filed August 31, 2006, the specification of which is incorporated herein by reference in its entirety.
Field Of The Invention
[0002] The present invention provides improved synthetic polymer hydrogel permeation layers for use on active electronic matrix devices for biological assays. The hydrogel permeation layers incorporate a dried coating of raffϊnose or combination of raffinose and stachyose to protect the permeation layer from degradation, thereby increasing shelf-life and expanding permissible shipping and storage temperatures. Additionally, the present invention provides increased cartridge-to-cartridge and lot-to-lot consistency during fabrication. The present invention also provides a preservative method for synthetic polymer hydrogel permeation layers having copolymerized attachment sites for biomolecules of interest, such as nucleic acid probes.
Background Of The Invention
[0003] The following description provides a summary of information relevant to the present invention. It is not an admission that any of the information provided herein is prior art to the presently claimed invention, nor that any of the publications specifically or implicitly referenced are prior art to the invention.
[0004] By placing a plurality of nucleic acid probes on a surface, and exposing the surface to a sample containing target nucleic acids, many hybridization reactions may be carried out on a sample at the same time, simultaneously generating hybridization data for several target nucleic acids (the reverse dot-blot technique). Similarly, by immobilizing nucleic acids from several samples onto the surface, several samples may be probed with the same oligonucleotide probe at the same time (the dot-blot technique). Originally, dot- blot and reverse dot-blot hybridizations were carried out using nucleic acid probes crudely blotted onto a nucleic acid-binding membrane or filter. In the past few decades, several tools have been designed to place nucleic acid probes at defined locations in high densities on various types of surfaces (glass, polymers, silicon nitride, etc.) by methods such as physical deposition (e.g., ink-jet, microspray, pin deposition, microchannel deposition) or by in-situ polymerization techniques (e.g., photo-deprotection methods.) Such "microchip" based DNA arrays have been of great interest in recent years due to their enormous ability to facilitate rapid analysis of genetic information. Although very advanced techniques are utilized to generate these types of arrays, they still employ parallel hybridization of DNA to the immobilized capture probes in a passive mode. In other words, the nucleic acids present in the entire sample volume interact with the entire array surface at the same time, to the same extent.
[0005] In contrast, active electronic matrix arrays use an electric field to facilitate the rapid transport and hybridization of DNA on microchips. In general, active matrix array devices contain an array of electronically addressable microelectrodes on a substrate, which provide electric field control over a variety of biomolecular reactions including DNA transport, hybridization and denaturation. By using the electrodes to apply an electric field to a solution containing charged molecules, such as nucleic acids, the charge molecules can be rapidly transported to and concentrated at the electrodes which are biased opposite the charge of the molecules. This allows the transport of nucleic acid probes or amplicons to the microlocations in a very efficient and specific manner for binding to attachment moieties at the microlocations (a process sometimes referred to as "programming" the locations), allowing the generation of arrays for dot-blot or reverse dot-blot formats. After the probes or amplicons are immobilized at the microlocations, the electric field can again be used to rapidly direct the second hybridization assay component to the microlocation. Thus, electric field regulated hybridization is one to three orders of magnitude faster than passive hybridization under the same conditions, overcoming several of the limitations of passive hybridization.
[0006] These arrays, also known as active programmable electronic matrix devices, or APEX devices, have been extensively described, e.g. in U.S. Pat. Nos. 6,051,380 and 6,245,508, incorporated herein by reference in their entirely. In general, the devices comprise an array of individually controllable microelectrodes on a substrate, and optionally comprise additional counter electrodes for opposite biasing. The microelectrodes are overlaid by a thin permeation layer, defining the microlocations of the device above the microelectrodes. In addition to facilitating the attachment of biomolecules by providing a matrix to affix attachment moieties (e.g., streptavidin,) the permeation layer separates the biomolecules from the electrode surface where hydrolysis and other potentially detrimental electrochemical reactions can occur. Although the permeation layer retards or prohibits the movement of the biomolecules towards the microelectrode, the permeation layer is sufficiently permeable to small molecules to permit ion exchange between the electrode surface and the buffer medium, allowing an electric current to flow. The active electronic matrix chips usually use electric current and voltage conditions wherein electric current densities are at least 0.04 nA/μm2 (about 200 nA for an 80 μm diameter microlocation) and/or potentials sufficient to hydrolyze water. The electric current density is defined as the electric current divided by the area of the electrode used to support it.
[0007] Additionally, the effectiveness of the translocation of charged biomolecules such as nucleotide oligomers within an electronically-driven system such as an active electronic matrix chip depends on the generation of the proper gradient of positively and negatively charged electrochemical species by the anode and cathode, respectively. For example, effective nucleic acid (i.e. either DNA or RNA) transport may be accomplished by generation of protons and hydroxyl anions when the potential at the anode is greater than +1.29 V with respect to a "saturated calomel electrode" (SCE). The transport efficiency of charged molecules increases with increasing current density, thus driving the desire for operation at higher voltage drops and current densities and, thus, the need for evermore robust permeation layers.
[0008] The application of an electric current through the permeation layer has also been found to produce considerable chemical and mechanical stress on the thin permeation layer coating at the electrode surface. It has been found that when such thin layers are applied onto electrodes without a covalent attachment to the electrode surface, the permeation layer is prone to separate or "delaminate" from the electrode interface. It is believed this delamination is caused by a change in the chemical make-up at the interface between the permeation layer and the electrode resulting from the application of electronic potential at the electrode and by physical disruption from charged ions and gases emanating from the electrode. Thus, the permeation layer must have sufficient mechanical strength and be relatively chemically inert in order to withstand the rigors of changes at the electrode surface without inordinate stretching or decomposition.
[0009] Thus, the permeation layer of active electronic matrix devices is an important element in the overall function of the device. It must be sufficiently permeable to small aqueous ions, yet efficiently sequester biomolecules from the electrode surface. In addition, it must be able to withstand significant chemical and mechanical forces while maintaining its integrity and shape. Several materials have been utilized which provide these qualities. Agarose with glyoxal crosslinked streptavidin (SA) has been used as a permeation layer on commercially available, active electronic matrix chips, and the results of electronic hybridization of DNA on these chips has been reported in several publications (e.g., Sosnowski, et al., Proc. Nat. Acad. Sci. USA, 94:1119-1123 (1997), and Radtkey, et al., Nucl. Acids Resrch., 28(7) el7 (2000.))
[0010] Agarose is a naturally sourced carbohydrate polymer hydrogel, containing long polymer strands which are crosslinked by non-covalent bonding. Such hydrogels are referred to as "physical hydrogels," as they derive their structure from non-covalent interactions, as compared to "chemical hydrogels," which derive their structure from covalent bonds (or cross-links) between the polymer strands. Agarose permeation layers provide good relative fluorescent intensity measurements in nucleic acid assays such as hybridization assays for single nucleotide polymorphisms (SNPs) and short tandem repeat sequences (STRs) in amplicon and capture-sandwich formats, and also in primer-extension type nucleic acid assays which have been used for gene-expression analysis.
[0011] However, some disadvantages are encountered in the use of agarose as a permeation layer material. Both the manufacturing process and the fact that agarose is a naturally-sourced product introduce some variation, which may vary performance from batch to batch, necessitating stricter quality controls. This is not ideal for large-scale manufacturing. Thus, an alternative material which is not naturally derived, which can be easily formed into a permeation layer on the device, and which will meet or exceed the operating standard of agarose, is greatly desirable.
[0012] Polyacrylamide and other synthetic polymer gels offer an alternative to agarose hydrogel permeation layers. These materials are wholly synthetic, and thus offer strict quality control of the components. In addition, they may be easily molded onto the microelectrode array surface with a high degree of uniformity across the entire device. Permeation layers which are between 1 and 2 μm thick in the dry state can be easily produced in this manner, and are amendable to high-throughput manufacture. After molding, streptavidin is covalently linked to the surface of the hydrogel to provide attachment sites for biotinylated oligonucleotide probes or amplicons. Although traditionally formulated polyacrylamide hydrogels made by the micromolding process are uniform, and offer better product control, they do not perform as well as the agarose streptavidin permeation layers in most nucleic acid assays. Thus, there is still a need for high-performance synthetic polymer hydrogel permeation layers for use on active electronic matrix chip devices. Moreover, there is a need for a permeation layer and method for manufacturing same that preserves and protects the permeation layer from degradation over time, thereby extending the shelf-life and expanding the permissible storage and shipping temperatures for the cartridge containing the permeation layer.
Summary Of The Invention
[0013] The current invention provides a dried coating of raffϊnose or a combination of raffinose and stachyose that serves to preserve and protect the permeation layer from degradation, increase the shelf-life, and expand the permissible storage and shipping temperatures for cartridges containing permeation layers. In a preferred embodiment, a permeation layer having copolymerized attachment sites is preserved and protected through addition of a dried raffinose coating. In another preferred embodiment, a combination of raffinose and stachyose is dried onto the permeation layer.
[0014] In one embodiment, the raffϊnose or combination of raffinose and stachyose coatings are formed by dissolving the sugar up to 10% (w/v) in 0.05% Proclin in deionized water. The resulting sugar solutions are then dispensed onto the permeation layers so as to saturate the permeation layer and subsequently allowed to dry at ambient temperatures. The dried coating may be washed away with commonly used buffers or water when the permeation layer is ready for use.
[0015] In another embodiment, the present invention discloses a method of coating a permeation layer overlying an electrode on a substrate including the steps of preparing a permeation layer, which may include, for example, a hydrogel or a sol-gel, preparing a sugar-based preservative solution, covering the permeation layer with the preservative solution and allowing the preservative solution to dry on the permeation layer. In some embodiments, the sugar-based preservative solution contains up to about 10% raffinose, while in other embodiments, the preservative solution contains a mixture of raffinose and stachyose in an amount up to about 10% by weight. In certain embodiments, the sugar- based preservative solution contains about 5% raffinose and about 5% stachyose by weight; other embodiments use a sugar-based preservative solution having about 1% raffinose and about 9% stachyose. In still other embodiments, the sugar-based preservative solution has a concentration of about 0% raffinose and about 10% stachyose by weight.
Brief Description of the Drawings
[0016] Fig. 1 is a chart showing a plot of the weight of various solutions as a function of the drying time.
[0017] Fig. 2 is a chart showing a plot of the average evaporation rate of various solutions.
Detailed Description Qf The Invention
[0018] As has been described, a key role in the function of active electronic matrix devices is played by the ion-permeable permeation layer which overlies the electrodes of the microlocations, or active sites, of these devices. As part of its function, the permeation layer provides attachment moieties for the attachment and immobilization of nucleic acids (or other specific binding entities, such as antibodies, or synthetic binding moieties such as pyranosyl-RNA). More importantly, the permeation layer separates the attached or tethered oligonucleotides and hybridized target DNA sequences from the highly reactive electrochemical environment generated immediately at the electrode surface. This highly reactive electrode surface, and the electrochemical products concentrated at the electrode surface, can rapidly destroy DNA probes and target DNA sequences which contact the surface or approach it too closely. Similar detrimental effects may be encountered with other macromolecular binding entities immobilized directly on the electrode surface. The permeation layer allows oligonucleotides and DNA fragments to be electronically concentrated above, rather than on, the electrode surface and hybridized to anchored complementary oligonucleotides while being protected from the reactive electrode surface and its immediate environment. The permeation layer also allows the gradual diffusion of the electrochemical reaction products (H+, OH', gasses, etc.) into the solution around the microlocation, allowing these products to balance the charge through the permeation layer by ion exchange and to react with buffer species. Thus, the design of the microelectrode and permeation layer, forming a microlocation structure, allows high current densities to be achieved in a very confined area, while minimizing the adverse effects produced by the electrode itself.
[0019] Once specific binding entities, such as nucleic acids, have been addressed to microlocations and immobilized, the addressed devices are able to control and actively carry out a variety of assays and reactions. Analytes or reactants can be transported by free field electrophoresis to any specific microlocation where the analytes or reactants are effectively concentrated and reacted with the specific binding entity at the microlocation. The sensitivity for detecting a specific analyte or reactant in dilute sample solutions is improved because of this concentrating effect. An additional advantage, which also improved the specificity of the assays carried out on the device, is that any un-bound analytes or reactants can be removed by reversing the polarity of a microlocation (also known as "electronic washing".)
[0020] The ability to produce a precisely controlled high current level, or density, at individual microlocations even allows the selective "de-hybridization" of DNA fragments, achieving hybridization selectivity at the level of single base mismatches. Thus, the devices can further improve the specificity of assays and reactions by providing another parameter to encourage mismatch de-hybridization (along with the more traditional parameters of temperature and chemical environment), which is known as "electronic stringency", or "electronic stringency control (ESC)." For DNA hybridization reactions which require different stringency conditions, ESC overcomes an inherent limitation of conventional array technologies, which must rely on stringency conditions which are consistent for all sites over the entire array. The active devices of this invention can electronically produce different stringency conditions at each microlocation. This adds another controllable factor affecting hybridization, along with the more traditional factors such as temperature, salt concentration and the presence of chaotropic agents. Thus, all hybridizations can be carried out optimally in the same bulk solution, and multiple hybridization reactions can be carried out with minimal outside physical manipulations. Additionally, it may be unnecessary to change temperature in some cases, and the need for multiple washing procedures is greatly reduced.
[0021] Thus, the permeation layer of active electronic matrix devices is more than simply a mechanical support to hold attachment sites for specific binding entities. It is also an important factor in the overall performance and efficiency of the devices in their active electronic modes. Unlike coatings or gel supports which have been described for passive array devices, e.g., the gel-block arrays described in U.S. Pat. No. 5,770,721, which simply use hydrogel matrices as an attachment scaffold, permeation layers used on the active electronic matrix devices described herein must also allow the efficient active electronic transport of biomolecules to the microlocations of the device, and be conducive to electronic hybridization and/or stringency procedures.
[0022] As noted above, agarose hydrogels containing glyoxal-crosslinked streptavidin have proven to be effective permeation layer materials on active electronic matrix chip devices. In general, these permeation layer formulations have provided good mean fluorescence indices with minimal background. SNP assays run on the SA-agarose chips have demonstrated nearly 100% accuracy in several tests run with actual genomic samples, together with a high discrimination ratio for discerning between alleles in both homozygous and heterozygous samples. In addition, very good results have been obtained using SA-agarose active electronic matrix chips in STR and gene expression analysis assays.
[0023] However, as also described above, the use of SA-agarose as a permeation layer has several disadvantages in the manufacturing context. Agarose is a physical hydrogel, which derives its semi-solid structure from non-covalent interactions between long polysaccharide chains. As these interactions are temperature-dependent, changes in temperature change the viscosity of the agarose solution: at higher temperatures, the solution is more liquid, while it forms a solidified gel at room temperature. Thus, in order to coat the agarose permeation layer onto the active electronic matrix chip electrode array, the agarose solution must be kept at a relatively high and constant temperature during the manufacturing process. This also must be balanced with maintaining the activity of the streptavidin crosslinked to the agarose in the solution, which can denature if the temperature is too high. The current manufacturing method is to spin-coat the agarose solution onto the active electronic matrix chip surface. Thus, the agarose permeation layer production methods add significantly to the resources expended in producing the device.
[0024] Although this produces a fairly uniform thickness, sub-micron variations in thickness are often encountered when comparing the thickness of the permeation layer over microlocations on different sites on the chip. In addition, because agarose is a natural product, batch to batch variability may be seen with regard to its chemical characteristics and its performance as a permeation layer. This variability in both the materials and the manufacturing methods decreases the number of active electronic matrix chips which will meet quality control standards, also increasing the resources necessary to produce high- quality active electronic matrix chips with agarose-based permeation layers.
[0025] In contrast to the naturally-sourced physical hydrogels, such as agarose, synthetic polymer chemical hydrogels offer a more easily controlled quality and production characteristics. Synthetic polymer hydrogels are produced from individual monomeric components, which are usually synthesized themselves from basic organic chemical components. The monomers can be purified to very high quality, with identical physical and chemical characteristics between production batches. The monomeric components can be mixed in various formulas with cross-linker moieties and polymerized by a triggered initiator (e.g., by exposure of a photoinitiator to UV). Thus, chemical hydrogels offer strict control over the rate of polymerization and the characteristics of the resulting hydrogel, as compared the control afforded by physical hydrogels formed by pre- polymerized chains. [0026] In addition, synthetic polymer hydrogels offer many advantages for mass production. They be easily molded onto the microelectrode array surface in situ with a high degree of uniformity across the entire device. Microreaction molds and methods of using them to form thin, uniform, synthetic polymer hydrogel layers on the surface of active electronic matrix chips have been described in WO 01/43938, Havens et al., incorporated herein by reference in its entirety. The microreaction molds disclosed comprise a mold cavity, with at least one side transparent to an electromagnetic radiation wavelength. In these systems, a small volume of the polymerization mixture (monomers, cross-linkers, and photoactivator) is placed into the mold cavity. The microelectrode array substrate is then pressed against the mold, forming an enclosed volume of the polymerization mixture on the substrate. The polymerization reaction is initiated by irradiating the enclosed volume with an appropriate wavelength of light for the photoinitiator (e.g., UV), and the polymerization reaction is allowed to proceed to completion. When the mold is removed, a thin, uniform, synthetic polymer hydrogel permeation layer has been formed on the microelectrode array.
[0027] Permeation layers which are between 1 and 2 μm thick, with sub-micron variations in thickness, can be easily produced in this manner, and are amendable to high- throughput manufacture. Multi-layer permeation layers (either overlaid or graft- polymerized onto the prior layers) be made in this manner as well, by using a series of molds with differing depths and/or widths. In addition, the molds can be designed to form individual permeation layers over each individual microelectrode, creating individually formed microlocations. In this manner, it is even possible to vary the permeation layer composition from microlocation to microlocation over the array of the active electronic matrix chip.
[0028] In the absence of stabilizers, cartridges containing permeation layers for use with the NanoChip™400 did not meet ideal shipping and storage requirements. For example, cartridges containing uncoated hydrogel permeation layers for use with Nanogen microarrays dehydrated and collapsed over time, thereby causing performance degradation. Surprisingly, it was found that addition of the sugar raffinose, alone or in combination with stachyose, to form a coating to the permeation layer resisted dessication and dramatically increased shelf-life and viability. [0029] The present invention is not limited to a particular type of permeation layer. Indeed, permeation layers comprising hydrogels and sol-gels as exemplified in U.S. Patent Nos. 6,303,082 and 6,960,298 may be used in conjunction with the preservatives and methods for preserving disclosed herein.
[0030] All patents, patent applications, and published patent applications, and other publications referred to herein are hereby incorporated herein in their entirety by reference, as if they were fully reproduced herein.
EXAMPLES
[0031] The invention will now be described in greater detail by reference to the following non-limiting examples regarding the production and use of preservatives applied to synthetic polymer hydrogel permeation layers for use on active electronic matrix devices.
EXAMPLE 1
[0032] In this Example, several different preservative solutions were introduced onto APO-10 permeation layers on ACV400 Fcos prior to the cartridge assemble step to prolong APO-10 permeation layer shelf life.
[0033] A hydrogel solution was prepared and a batch of DIa ACV400 Fcos was molded. The Fcos with permeation layer was washed in 0.05% Proclin water for 1 hour with out stirring, then rinsed and dried with N2. The preservative solutions shown in Table 1 were made and 20μl of solution was pipetted into each Fcos flow-cell. The permeation layer was allowed to swell in the solutions for 20 minutes. The solutions were then pipetted out of the flow-cell and dried with N2. The Fcos was stored in nitrogen-purged desiccators for about 72 hours. The Fcos permeation layers were assembled into cartridges. Finished cartridges were placed in 400C incubators for accelerated stability tests.
Table 1 ~ Preservative Solutions
Figure imgf000013_0001
[0034] The cartridge lot number was A10254. There were 29 normal DIa (APO-10, 20mg) cartridges and 41 cartridges treated with preservative solutions described in Table 1. The results are summarized in table 2 below. Table 2.
Figure imgf000013_0002
[0035] There were 16 broken Fcos (out of 86) due to clamping issues arising during the cartridge assembly process. This particular lot of cartridges demonstrated unusual conductivities. Moreover, many of the cartridges had particulates on the surface of the permeation layers, regardless of what kind of preservative solutions were used. EXAMPLE 2
[0036] In this example, preservative sugar solutions were applied to APO-IO permeation layers on ACV400 Feos prior to cartridge assembly stage to investigate prolonged permeation layer shelf-life.
[0037] A solution of 0.005% Proclin water was prepared by adding Ig of Proclin 300 into 2L of deionized water. The mixture was stirred for 10 minutes and filtered with a 0.2μm bottle-top filter. A DIa hydrogel solution having the following mixing volume was made: 165μl of monomer-detergent solution plus 110 μl modified Streptavidin and 30.6 μl 2% Darocur in DMSO. A batch of 75 Fcos was molded under the following conditions: UV =8.7mW without OD filter (set/read = 1120/1122mW) with a compression of 165mg. The batch was subsequently washed in a Petri-dish for one hour with Proclin water, then rinsed and dried with N2.
[0038] The permeation layers were then treated with the preservative solutions described in Table 3. Table 3.
Figure imgf000014_0001
[0039] Specifically, 15 μl of each preservative solution was transferred into each Fcos immediately after the Fcos were rinse and dried. There were 6 Fcos per solution. The treated Fcos were placed into 37°C incubators for two hours before removal from the oven and storage in nitrogen desiccators until cartridges were assembled. Assembled cartridges were placed in a 400C incubator for the acceleration stability test. [0040] The six Fcos that were treated with solution #12 did not have cracks, while the permeation layers treated with the other solutions did exhibit cracks.
EXAMPLE 3
[0041] In this example preservative sugar solutions were introduced to APO-10 permeation layer on ACV400 Fcos prior to cartridge assembly step to prolong the permeation layer shelf-life. This experiment investigated 7 different preservative solutions, which were introduced to permeation layers that had dried for 24 hours dry as well as to permeation layers that had been immediately dried. The treated perm layers were held at 23 °C and 37°C for drying.
[0042] A batch of permeation layers was molded using the following procedure: A solution of 0.005% Proclin water was prepared and filtered. Specifically, 9mg of Darocur 4265 was added into 450μl of DMSO to made 2% initiator solution. The DIa hydrogel solution was formulated with the following mixing volume: 165 μl of monomer detergent, 1 lOμl of modified streptavidin, and 30.6μl of initiator solution. A batch of 59 Fcos was molded having the following variables: UV = 8.6mW without OD filter (set/read = 1100/1122m W/cm2), having a compression force = 165mg +/- 15mg. The molded Fcos were rinsed and washed in Petri-dishes for one hour, rinsed a second time, and dried with N2. The finished Fcos were stored in refrigerator at 4°C for 24 hours.
[0043] Preservative sugar solutions were made as described in table 4 below. Table 4.
Figure imgf000015_0001
[0044] Preservative solutions were added to permeation layers under the conditions described in table 5 below: Table 5.
Figure imgf000016_0001
[0045] The finished cartridges were labeled as indicated in the table above. The first letter refers to the condition of the permeation layer when the sugar solution was added. The two digit number in the middle refers to the sugar solution number. The last two digit number refers to the drying temperatures after the permeation layer was coated with the sugar solution.
[0046] For the D-xx-23 and D-xx-37 Fcos, 15μl of preservative solutions were added in the dry permeation layers. Then, the sugar-coated Fcos was stored at 23 °C and 370C for 48 hours before transfer to cartridge assembly.
[0047] For the W- xx-23 and W-xx-37 Fcos, the permeation layers were re-hydrated in water for one hour and dried with nitrogen. After drying, sugar solutions were applied to the permeation layers and allowed to incubate at 23°C or 37°C for 48 hours. The rehydration step was added to determine whether the cracking observed in some sugar- coated permeation layers was the result of polymer shrinkage during dehydration.
[0048] The table below shows the number of Fcos that were treated with different sugar solutions.
Table 6.
Figure imgf000016_0002
Figure imgf000017_0001
[0049] The treated Fcos were assembled into cartridges and held at 40°C for accelerated stability study. The sugar-coated permeation layers were monitored over time for crystallization and cracking. For this experiment, most of the treated permeation layers were positive, as described in the following table. Table 7.
Figure imgf000017_0002
EXAMPLE 4
[0050] In this experiment, the list of preservative materials was narrowed to two candidates, raffϊnose and PVP. In addition, add Triton X-100 and Ethanol were added to the sugar mixtures to accelerate the drying process and improve surface wettability.
[0051] A hydrogel solution was prepared. Two liters of 0.005% Proclin water were preparedand used to make preservative sugar solutions and wash the permeation layers. A 2% initiator solution was prepared by adding 11.5mg of Darocur 4265 into 575μl of DMSO. The final hydrogel solution was formulated with the following mixing volume: 165 μl of monomer detergent, 110 μl modified streptavidin and 30.6 μl initiator solution. The solution was filtered with 0.2 μm Millex LG syringe filter.
[0052] A mold station was set up using the following characteristics. UV intensity = 8.8mW/131 μw (open/close OD filter)( EXFO set/read = 900/107ImW). Compression force = 175mg +/-15. During the molding process, compression force fluctuated from Fcos to Fcos. The force was anywhere from 139mg to 217mg, which was unusual. Polymerization time was 30 second without OD filter.
[0053] The molded Fcos were rinsed with 0.005% Proclin water for five seconds each using a squirt bottle. The Fcos were soaked in large Petri-dish with Proclin water for one hour and rinsed again with Proclin water. The Fcos were then dried with N2 and inspected before treatment with preservative sugar solutions.
[0054] The molded Fcos were treated with different preservative solutions as in the table below.
Table 8.
Figure imgf000018_0001
Figure imgf000019_0001
[0055] A total of 15 μl of sugar solution was dispended onto each Fcos, which were then stored in closed Petri-dishs, 10 Fcos each, at room condition for 64 hours. The dried Fcos were visually inspected and transferred to cartridge assembly. During the cartridge assembly process, the Fcos were kept at room condition. After the cartridges were assembled, they were inspected again and viewed under a confocal microscope. The cartridges were stored at different temperatures for stability study.
[0056] The results are summarized in the following table. Table 9.
Figure imgf000019_0002
[0057] Assembled and treated cartridges were stored at various conditions, as shown in the following table. Table 10.
Figure imgf000020_0001
[0058] In general, PVP-treated permeation layers appear to crack when stored at room temperature or higher. Raffinose treated cartridges were more stable. All of the cartridges stored at 550C for 13 days were cracked.
EXAMPLE 5
[0059] In this example, the time it takes for the sugar coated layer to dry before transfer the Fcos to cartridge assembly process was determined.
[0060] The evaporation rate of the sugar solutions was determined. Six empty ACV400 Fcos (with no perm layer) were used. The weight of the Fcos was recorded before and after 15μl of solution was dispended and evenly spread out onto the Fcos' flow-cell. Each of the Fcos were stored in a large Petri-dish with the lid closed. The Petri-dish was placed on lab bench at normal room condition (humidity was about 40 +/-10). The weights of the Fcos were measured over time to determine the evaporation rate of the solution. The solutions used for this study were water, 5% ethanol, 10% Raffinose, and 10% PVP.
[0061] The weight of the solutions was calculated and plotted it as a function of drying time. The slope of the linear fit line on graph 2 provides the average evaporation rate of the solutions. The calculated dry time is 4.7 hours. As shown in the graph below, the 5% ethanol curve has a slightly steeper slope, indicating that the ethanol solution vaporizes faster than water and sugar solutions. [0062] The end values of all the sugar solution curves at the 6 hour point were slightly higher than the water and ethanol, indicating that about 10% of the materials were left over after the water completely evaporated. Table 11.
Figure imgf000021_0001
Table 12.
Figure imgf000021_0002
[0063] Based on the information provided in Table 11 , the weight of the solutions was plotted as a function of drying time as shown in Figure 1. The 5% ethanol curve had a slightly steeper slope than the other curves, indicating that the ethanol solution evaporates quicker than the water and sugar solutions. The end values of all the sugar solutions curves at 6 hours were slightly higher than water and ethanol indicating that about 10% of the material remained after the water completely evaporated. Figure 2 shows the slope of a linear fit line demonstrating the average evaporation rate of the solutions. The calculated drying time was 4.7 hours. EXAMPLE 6
[0064] In this experiment, stachyose was added to the raffmose preservative solutions to determine whether such an addition would alleviate cracking in the permeation layers.
[0065] Solutions of 10% raffinose and 10% stachyose were prepared. The 10% stachyose solution was made by dissolving 300mg of stachyose hydrate powder onto 2.7ml of 0.05% Proclin 300 solution. Test solutions were prepared by mixing the 10% Raffmose and 10% Stachyose solutions together at different volume ratios. A total of six mixtures were made as shown in the table below. Table 13.
Figure imgf000022_0001
Crystallization Test on Cover Glasses
[0066] The test solutions were pipetted onto cover glasses, 15μl of solution per glass, and allowed to incubate at room temperature in large Petri-dishes to evaporate. For each solution, sixty cover glasses were used. Ten out of the sixty test samples were added with a very small amount of raffmose powder to catalyze crystallization of the solution.
[0067] The results showed that all of the 50 evaporation samples of each test solution did not crystallize, thereby demonstrating that slow evaporation of the solutions at room conditions was not the cause of the crystallization. However, during the evaporation period, some of the 10 test samples containing additional raffinose powder crystallized, suggesting that when non-solvent materials are introduced into the system, supersaturation of the sugar solutions may occur and induce cracking. Thus, solutions containing stachyose or solutions having reduced concentrations of raffinose decrease the chance of the sugar solutions reaching super saturated levels and crystallizing. EXAMPLE 7
[0068] In this hold time study, 10% Raffmose treated H4 hydrogel molded NanoChip® 400 FCOS were held for 11 days, as opposed to the standard overnight period. After 11 days, the FCOS were inspected under microscope, assembled into cartridges and subjected to FV QC assay test.
[0069] All of the FCOS were inspected under a microscope and appeared to be normal after 11 days of storage at ambient conditions. The room temperature and relative humidity were recorded as shown below. Table 14.
Figure imgf000023_0001
[0070] Modifications and other embodiments of the invention will be apparent to those skilled in the art to which this invention relates having the benefit of the foregoing teachings, descriptions, and associated drawings. The present invention is therefore not to be limited to the specific embodiments disclosed but is to include modifications and other embodiments which are within the scope of the appended claims. All references are herein incorporated by reference.

Claims

We Claim:
1. A sugar-based coating for a permeation layer overlying an electrode on a substrate, the coating comprising a solution of raffmose.
2. The sugar-based coating of claim 1 , wherein the solution of raffinose further comprises raffinose in an amount of between about 0 to 10% by weight.
3. The sugar-based coating of claim 2, wherein the permeation layer comprises a material selected from the group consisting of hydrogels and sol-gels.
4. A sugar-based coating for a permeation layer overlying an electrode on a substrate, the coating comprising a solution of raffinose and stacyhose.
5. The sugar-based coating of claim 4, wherein the solution of raffinose and stachyose further comprises raffinose and stachyose in an amount of between about 0 to 10% by weight.
6. The sugar-based coating of claim 5, wherein the permeation layer comprises a material selected from the group consisting of hydrogels and sol-gels.
7. A method of coating a permeation layer overlying an electrode on a substrate, the method the comprising the steps of: a. preparing a permeation layer; b. preparing a sugar-based preservative solution; c. covering the permeation layer with an amount of preservative solution sufficient to substantially cover an outside surface of the permeation layer; and d. allowing preservative solution to dry on the permeation layer.
8. The method of claim 7, wherein the permeation layer comprises a material selected from the group consisting of hydrogels and sol-gels.
9. The method of claim 8, wherein the sugar-based preservative solution comprises raffmose in an amount of between about 0 to 10% by weight.
10. The method of claim 8, wherein the sugar-based preservative solution comprises raffinose and stachyose in an amount of between about 0 to 10% by weight.
11. The method of 10, wherein the sugar-based preservative solution comprises about 5% raffinose and about 5% stachyose by weight.
12. The method of 10, wherein the sugar-based preservative solution comprises about 9% raffinose and about 1% stachyose by weight.
13. The method of 10, wherein the sugar-based preservative solution comprises about 0% raffinose and about 10% stachyose by weight.
PCT/US2007/077188 2006-08-31 2007-08-30 Compositions and methods for preserving permeation layers for use on active electronic matrix devices WO2008028011A2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US84178106P 2006-08-31 2006-08-31
US60/841,781 2006-08-31
US11/846,187 2007-08-28
US11/846,187 US7687103B2 (en) 2006-08-31 2007-08-28 Compositions and methods for preserving permeation layers for use on active electronic matrix devices

Publications (2)

Publication Number Publication Date
WO2008028011A2 true WO2008028011A2 (en) 2008-03-06
WO2008028011A3 WO2008028011A3 (en) 2008-10-09

Family

ID=39136863

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2007/077188 WO2008028011A2 (en) 2006-08-31 2007-08-30 Compositions and methods for preserving permeation layers for use on active electronic matrix devices

Country Status (2)

Country Link
US (1) US7687103B2 (en)
WO (1) WO2008028011A2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020204975A1 (en) * 2019-04-05 2020-10-08 Instrumentation Laboratory Company Multi-enzymatic biosensors and stabilization of multi-enzymatic biosensors at room temperature

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008154225A2 (en) 2007-06-06 2008-12-18 Bayer Healthcare Llc Microdeposition system for a biosensor
US10466511B2 (en) * 2009-12-01 2019-11-05 The Hong Kong University Of Science And Technology Compositions containing thermally-induced self-assembly of nonionic surfactants and their application in smart glass technologies
US9512422B2 (en) * 2013-02-26 2016-12-06 Illumina, Inc. Gel patterned surfaces

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5346604A (en) * 1992-10-21 1994-09-13 Diametrics Medical, Inc. Self-activating chemical sensor system

Family Cites Families (95)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE30130E (en) 1975-09-22 1979-10-30 Cincinnati Milacron Inc. Liquid reaction molding press
US3981671A (en) 1975-09-22 1976-09-21 Cincinnati Milacron, Inc. Liquid reaction molding press
US4205028A (en) 1979-01-11 1980-05-27 Ferro Corporation Forming protective skin on intricately molded product
US4284399A (en) 1980-06-23 1981-08-18 American Optical Corporation Contact lens mold
FR2486864A1 (en) 1980-07-21 1982-01-22 Pont A Mousson PROCESS FOR INJECTION MOLDING OF PLASTIC COATED PARTS AND DEVICE FOR IMPLEMENTING THE SAME
EP0047645B1 (en) 1980-09-05 1984-11-28 Matsushita Electric Industrial Co., Ltd. A method of producing an information recording disk
US4552633A (en) 1982-09-29 1985-11-12 Japan Atomic Energy Research Institute Fine particulate for use in clinical testing and a process for producing thereof
US5217492A (en) 1982-09-29 1993-06-08 Bio-Metric Systems, Inc. Biomolecule attachment to hydrophobic surfaces
EP0243501A1 (en) 1985-10-30 1987-11-04 Showa Denko Kabushiki Kaisha Curable composition and method for molding it
GB8530715D0 (en) 1985-12-13 1986-01-22 Unilever Plc Microchemical testing
US5034428A (en) 1986-06-19 1991-07-23 Board Of Regents Of The University Of Washington Immobilized biomolecules and method of making same
JPS6334108A (en) 1986-07-30 1988-02-13 Hitachi Ltd Manufacture of substrate for optical disc and device therefor
US4787963A (en) 1987-05-04 1988-11-29 Syntro Corporation Method and means for annealing complementary nucleic acid molecules at an accelerated rate
US5238613A (en) 1987-05-20 1993-08-24 Anderson David M Microporous materials
US5244799A (en) 1987-05-20 1993-09-14 Anderson David M Preparation of a polymeric hydrogel containing micropores and macropores for use as a cell culture substrate
FR2617172B1 (en) 1987-06-25 1993-07-02 Charbonnages Ste Chimique PREPARATION OF INVERTED MICROLATEX FOR USE AS FLOAT AND DRAINAGE ADDITIVES AND FOR THE ABSORPTION AND RETENTION OF AQUEOUS FLUIDS
US6054270A (en) 1988-05-03 2000-04-25 Oxford Gene Technology Limited Analying polynucleotide sequences
US5212050A (en) 1988-11-14 1993-05-18 Mier Randall M Method of forming a permselective layer
US6306594B1 (en) 1988-11-14 2001-10-23 I-Stat Corporation Methods for microdispensing patterened layers
US5200051A (en) 1988-11-14 1993-04-06 I-Stat Corporation Wholly microfabricated biosensors and process for the manufacture and use thereof
US5237016A (en) 1989-01-05 1993-08-17 Siska Diagnostics, Inc. End-attachment of oligonucleotides to polyacrylamide solid supports for capture and detection of nucleic acids
DE3909456A1 (en) 1989-03-22 1990-09-27 Roehm Gmbh IMPROVED METHOD FOR THE PRODUCTION OF IMMOBILIZED ANTIKOERPERS
US5026785A (en) 1989-05-12 1991-06-25 The United States Of America As Represented By The Department Of Health And Human Services Avidin and streptavidin modified water-soluble polymers such as polyacrylamide, and the use thereof in the construction of soluble multivalent macromolecular conjugates
US5143854A (en) 1989-06-07 1992-09-01 Affymax Technologies N.V. Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof
US5491097A (en) 1989-06-15 1996-02-13 Biocircuits Corporation Analyte detection with multilayered bioelectronic conductivity sensors
CA2028804C (en) 1989-11-21 2000-06-20 Howard J. Buttery Biomosaic polymers and method for preparing same
GB9006726D0 (en) 1990-03-26 1990-05-23 Ici Plc Micro-emulsions
US5147297A (en) 1990-05-07 1992-09-15 Alza Corporation Iontophoretic delivery device
US5164162A (en) 1990-05-21 1992-11-17 The Dow Chemical Company Mixing head with sleeved quieting chamber
US5304428A (en) * 1990-06-05 1994-04-19 Fukuda Metal Foil And Powder Co., Ltd. Copper foil for printed circuit boards
JP2772443B2 (en) 1990-06-18 1998-07-02 シャープ株式会社 Semiconductor package sealing method and sealing device
DE69126064T2 (en) 1990-06-22 1997-08-28 Hoffmann La Roche Detection of weak metabolizing agents of drugs
US5527670A (en) 1990-09-12 1996-06-18 Scientific Generics Limited Electrochemical denaturation of double-stranded nucleic acid
ES2065181T3 (en) 1991-03-11 1995-02-01 Alza Corp IONTOPHORETICAL SUPPLY DEVICE AND PROCEDURE FOR ITS MANUFACTURE.
JP2686682B2 (en) 1991-10-16 1997-12-08 いすゞ自動車株式会社 Manufacturing method of molded products
JP3168006B2 (en) 1991-10-21 2001-05-21 コーネル・リサーチ・フアウンデーシヨン・インコーポレーテツド Columns with macroporous polymer media
US5605662A (en) 1993-11-01 1997-02-25 Nanogen, Inc. Active programmable electronic devices for molecular biological analysis and diagnostics
US6048690A (en) 1991-11-07 2000-04-11 Nanogen, Inc. Methods for electronic fluorescent perturbation for analysis and electronic perturbation catalysis for synthesis
US5632957A (en) 1993-11-01 1997-05-27 Nanogen Molecular biological diagnostic systems including electrodes
US6051380A (en) 1993-11-01 2000-04-18 Nanogen, Inc. Methods and procedures for molecular biological analysis and diagnostics
US6017696A (en) 1993-11-01 2000-01-25 Nanogen, Inc. Methods for electronic stringency control for molecular biological analysis and diagnostics
US5849486A (en) 1993-11-01 1998-12-15 Nanogen, Inc. Methods for hybridization analysis utilizing electrically controlled hybridization
US5846708A (en) 1991-11-19 1998-12-08 Massachusetts Institiute Of Technology Optical and electrical methods and apparatus for molecule detection
US5667667A (en) 1992-04-24 1997-09-16 Isis Innovation Limited Electrochemical treatment of surfaces
WO1994007593A1 (en) 1992-10-01 1994-04-14 Australian Membrane And Biotechnology Research Institute Improved sensor membranes
FR2702067B1 (en) 1993-02-23 1995-04-14 Schlumberger Ind Sa Method and device for manufacturing memory cards.
US5460872A (en) 1993-03-26 1995-10-24 W. L. Gore & Associates, Inc. Process for coating microporous substrates and products therefrom
US6306348B1 (en) 1993-11-01 2001-10-23 Nanogen, Inc. Inorganic permeation layer for micro-electric device
US5824473A (en) 1993-12-10 1998-10-20 California Institute Of Technology Nucleic acid mediated electron transfer
US5744627A (en) 1994-01-28 1998-04-28 Prolinx, Inc. Boronic compound complexing reagents and complexes
US5777148A (en) 1994-01-28 1998-07-07 Prolinx, Inc. Boronic compound complexing reagents and highly stable complexes
JP3640996B2 (en) 1994-01-28 2005-04-20 ミネソタ マイニング アンド マニュファクチャリング カンパニー Polymer composite material
US5670557A (en) 1994-01-28 1997-09-23 Minnesota Mining And Manufacturing Company Polymerized microemulsion pressure sensitive adhesive compositions and methods of preparing and using same
DE4421901A1 (en) 1994-06-23 1996-01-04 Bayer Ag A rapid DNA test for the detection of quinolone-resistant Staphylococcus aureus pathogens in clinical specimens
JP3093943B2 (en) 1994-12-08 2000-10-03 シャープ株式会社 Manufacturing method of liquid crystal display device
CA2168529A1 (en) 1995-02-02 1996-08-03 Tatsuichiro Kon Transparent conductive sheet
US6066448A (en) 1995-03-10 2000-05-23 Meso Sclae Technologies, Llc. Multi-array, multi-specific electrochemiluminescence testing
US6673533B1 (en) 1995-03-10 2004-01-06 Meso Scale Technologies, Llc. Multi-array multi-specific electrochemiluminescence testing
US5624711A (en) 1995-04-27 1997-04-29 Affymax Technologies, N.V. Derivatization of solid supports and methods for oligomer synthesis
US5534132A (en) 1995-05-04 1996-07-09 Vreeke; Mark Electrode and method for the detection of an affinity reaction
US6099783A (en) 1995-06-06 2000-08-08 Board Of Trustees Operating Michigan State University Photopolymerizable compositions for encapsulating microelectronic devices
US5763503A (en) 1995-06-07 1998-06-09 Esschem, Inc. Radiation-curable, moldable material, methods for curing it and molded articles obtained therefrom
US5889104A (en) 1996-01-11 1999-03-30 W. L. Gore & Associates, Inc. Low dielectric constant material for use as an insulation element in an electronic device
DE19705303C2 (en) 1996-02-16 2002-11-21 Karlsruhe Forschzent Process for the production of small and micro parts
US6121489A (en) 1996-03-05 2000-09-19 Trega Biosciences, Inc. Selectively N-alkylated peptidomimetic combinatorial libraries and compounds therein
ZA975891B (en) 1996-07-05 1998-07-23 Combimatrix Corp Electrochemical solid phase synthesis of polymers
US6039897A (en) 1996-08-28 2000-03-21 University Of Washington Multiple patterned structures on a single substrate fabricated by elastomeric micro-molding techniques
CA2271717A1 (en) 1996-12-12 1998-06-18 Prolume, Ltd. Apparatus and method for detecting and identifying infectious agents
US6458584B1 (en) 1996-12-23 2002-10-01 University Of Chicago Customized oligonucleotide microchips that convert multiple genetic information to simple patterns, are portable and reusable
JPH10214521A (en) 1997-01-31 1998-08-11 Tokai Kogyo Kk Multilayer conductive material arrangement structure, multilayer conductive material device, and manufacture thereof
US6143412A (en) 1997-02-10 2000-11-07 President And Fellows Of Harvard College Fabrication of carbon microstructures
JP3161362B2 (en) 1997-05-01 2001-04-25 富士ゼロックス株式会社 Microstructure, its manufacturing method, its manufacturing apparatus, substrate and molding die
US6099805A (en) 1997-07-09 2000-08-08 Trw Inc. Singlet-delta oxygen generator
US5981734A (en) 1997-07-17 1999-11-09 University Of Chicago Methods for immobilizing nucleic acids on a gel substrate
US6121027A (en) 1997-08-15 2000-09-19 Surmodics, Inc. Polybifunctional reagent having a polymeric backbone and photoreactive moieties and bioactive groups
US6093302A (en) 1998-01-05 2000-07-25 Combimatrix Corporation Electrochemical solid phase synthesis
US6112908A (en) 1998-02-11 2000-09-05 Rentiers Machinery Pty, Ltd. Membrane laminates and methods for their preparation
US6290839B1 (en) 1998-06-23 2001-09-18 Clinical Micro Sensors, Inc. Systems for electrophoretic transport and detection of analytes
US6197145B1 (en) 1998-08-17 2001-03-06 Ford Motor Company Method of laminating a flexible circuit to a substrate
CN100349660C (en) 1998-10-19 2007-11-21 Toto株式会社 Stainproof material and method for manufacturing the same, and coating composition and apparatus therefor
US6197881B1 (en) 1999-08-18 2001-03-06 Biopixel Ltd. Electrically conductive copolymers and their preparation
US6451191B1 (en) 1999-11-18 2002-09-17 3M Innovative Properties Company Film based addressable programmable electronic matrix articles and methods of manufacturing and using the same
US6303082B1 (en) 1999-12-15 2001-10-16 Nanogen, Inc. Permeation layer attachment chemistry and method
US6524517B1 (en) 1999-12-15 2003-02-25 Nanogen, Inc. Methods for molding and grafting highly uniform polymer layers onto electronic microchips
US6491061B1 (en) 2000-02-25 2002-12-10 University Of New Mexico Stimuli responsive hybrid materials containing molecular actuators and their applications
US6631085B2 (en) 2000-04-28 2003-10-07 Matrix Semiconductor, Inc. Three-dimensional memory array incorporating serial chain diode stack
JP3709919B2 (en) 2000-08-01 2005-10-26 日本電気株式会社 Equipment for measuring components in liquid samples
US6824974B2 (en) 2001-06-11 2004-11-30 Genorx, Inc. Electronic detection of biological molecules using thin layers
US6444318B1 (en) 2001-07-17 2002-09-03 Surmodics, Inc. Self assembling monolayer compositions
US6960298B2 (en) 2001-12-10 2005-11-01 Nanogen, Inc. Mesoporous permeation layers for use on active electronic matrix devices
US6841379B2 (en) 2002-05-15 2005-01-11 Beckman Coulter, Inc. Conductive microplate
EP1679508B1 (en) * 2003-10-30 2010-07-21 Arkray, Inc. Biosensor and method for preparation thereof
EP1680178A4 (en) * 2003-10-31 2008-01-02 Alza Corp System and method for transdermal vaccine delivery
US7462452B2 (en) 2004-04-30 2008-12-09 Pacific Biosciences Of California, Inc. Field-switch sequencing
US20060105355A1 (en) * 2004-11-18 2006-05-18 Karl Maurer Electrode array device having an adsorbed porous reaction layer having a linker moiety

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5346604A (en) * 1992-10-21 1994-09-13 Diametrics Medical, Inc. Self-activating chemical sensor system

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020204975A1 (en) * 2019-04-05 2020-10-08 Instrumentation Laboratory Company Multi-enzymatic biosensors and stabilization of multi-enzymatic biosensors at room temperature
WO2020204973A1 (en) * 2019-04-05 2020-10-08 Instrumentation Laboratory Company Urea biosensors and stabilization of urea biosensors at room temperature
KR20210013626A (en) * 2019-04-05 2021-02-04 인스트루멘테이션 래보라토리 컴퍼니 Compositions and methods for improved creatinine measurement accuracy, and use thereof
KR20210013625A (en) * 2019-04-05 2021-02-04 인스트루멘테이션 래보라토리 컴퍼니 Urea biosensor and stabilization of urea biosensor at room temperature
JP2021527224A (en) * 2019-04-05 2021-10-11 インストゥルメンテーション ラボラトリー カンパニー Stabilization of urea biosensors and urea biosensors at room temperature
US11293890B2 (en) 2019-04-05 2022-04-05 Instrumentation Laboratory Company Multi-enzymatic biosensors and stabilization of multi-enzymatic biosensors at room temperature
US11327042B2 (en) 2019-04-05 2022-05-10 Instrumentation Laboratory Company Compositions and methods for improved creatinine measurement accuracy and uses thereof
JP7135121B2 (en) 2019-04-05 2022-09-12 インストゥルメンテーション ラボラトリー カンパニー Urea biosensor and stabilization of urea biosensor at room temperature
US11460431B2 (en) 2019-04-05 2022-10-04 Instrumentation Laboratory Company Urea biosensors and stabilization of urea biosensors at room temperature
KR102519406B1 (en) * 2019-04-05 2023-04-10 인스트루멘테이션 래보라토리 컴퍼니 Urea biosensors and stabilization of urea biosensors at room temperature
KR102574622B1 (en) 2019-04-05 2023-09-06 인스트루멘테이션 래보라토리 컴퍼니 Compositions and methods for improved creatinine measurement accuracy, and uses thereof
US11761921B2 (en) 2019-04-05 2023-09-19 Instrumentation Laboratory Company Outer membrane compositions for creatinine/creatine sensors

Also Published As

Publication number Publication date
WO2008028011A3 (en) 2008-10-09
US20080069962A1 (en) 2008-03-20
US7687103B2 (en) 2010-03-30

Similar Documents

Publication Publication Date Title
EP1463576B1 (en) Mesoporous permeation layers for use on active electronic matrix devices
EP2649196B1 (en) A biosensor using impedimetric real-time monitoring
US5741700A (en) Method of immobilizing water-soluble bioorganic compounds on a capillary-porous carrier
Gao et al. Controlling droplet motion on an organogel surface by tuning the chain length of DNA and its biosensing application
KR20150022751A (en) Coated substrate for biological reaction systems
Liu et al. Space-confinment-enhanced fluorescence detection of DNA on hydrogel particles array
US7687103B2 (en) Compositions and methods for preserving permeation layers for use on active electronic matrix devices
US20020090739A1 (en) Silsesquioxane-coated substrates for immobilizing biomolecules
EP1726661A1 (en) Method for manufacturing a biosensor element
CN1995369A (en) Solid phase preparation of nucleic acid molecule clone
KR101319104B1 (en) Method for fixing a supercoiled dna and the use for analysing the dna repair
US7491496B2 (en) Method for immobilizing nucleic acid and method for manufacturing biosensor using the same method
US7195908B2 (en) Supports treated with triamine for immobilizing biomolecules
Pappaert et al. Diffusion limitation: A possible source for the occurrence of doughnut patterns on DNA microarrays
JP2008002974A (en) Covering body and using method of covering body
Al-Ahmed et al. Biomedical perspectives of polyaniline based biosensors
CN111094622B (en) Fracture passivation in a matrix
KR20220073489A (en) Functional microarray chip
US20060166285A1 (en) Charged permeation layers for use on active electronic matrix devices
KR20030049802A (en) Discrimination method of hybridization between probes and nucleotides in sample on the bio chip using enzyme reaction
US20230347312A1 (en) Systems and methods for liquid deposition
CN104805509A (en) Carboxyl-modified gene chip substrate and preparation method thereof
JP3979198B2 (en) Nucleic acid immobilization carrier
EP3480308A1 (en) Composition for preventing drying of gel, gel composite and dna chip containing said composite, and method for producing said composition, composite, and chip
De Oliveira et al. First characterization of a biosensor for large DNA molecules using quartz crystal microbalance and impedance spectroscopy

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07841590

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

NENP Non-entry into the national phase

Ref country code: RU

122 Ep: pct application non-entry in european phase

Ref document number: 07841590

Country of ref document: EP

Kind code of ref document: A2